Evaluation of the Duration of Human Factor VIII Expression in Nonhuman Primates After Systemic Delivery of an Adenoviral Vector-Reference-Cited by-同舟云学术

Evaluation of the Duration of Human Factor VIII Expression in Nonhuman Primates After Systemic Delivery of an Adenoviral Vector

Published:2002-07-20 Issue:11 Volume:13 Page:1331-1336
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Andrews Julie L.¹,Shirley Pamela S.¹,Iverson William O.²,Sherer Alfred D.²,Markovits Judit E.²,King Laura¹,Lyons Russette M.¹,Kaleko Michael¹,Connelly Sheila¹

Affiliation:

1. Genetic Therapy, Inc. (A Novartis Company), Gaithersburg, MD 20878

2. Novartis Pharmaceuticals, Inc., Summit, NJ 07901

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104303402760128559

Reference26 articles.

1. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector

2. Adenoviral Vector-Mediated Expression of Physiologic Levels of Human Factor VIII in Nonhuman Primates

3. New aspects of hepatic fibrosis

4. Adenovirus-Mediated Factor VIII Gene Expression Results in Attenuated Anti-Factor VIII-Specific Immunity in Hemophilia A Mice Compared with Factor VIII Protein Infusion

5. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives;Seminars in Thrombosis and Hemostasis;2024-04-08

2. Gene Therapeutic Strategies for Peripheral Artery Disease and New Opportunities Provided by Adeno-Associated Virus Vectors;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-06

3. Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model;Blood;2011-09-29

4. Prospects for the Use of Artificial Chromosomes and Minichromosome-Like Episomes in Gene Therapy;Journal of Biomedicine and Biotechnology;2010

5. Advancements in gene transfer-based therapy for hemophilia A;Expert Review of Hematology;2009-12